SCHEMBL19615775

SCHEMBL19615775

COC(=O)c1ccnc(C(=O)C2CC2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.51
KDM6B O15054 3/20 0.51
KDM5C P41229 3/20 0.51
KDM4C Q9H3R0 3/20 0.51
KDM2A Q9Y2K7 3/20 0.51
KDM3A Q9Y4C1 3/20 0.51
ALOX15 P16050 2/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
ALDH1A1 P00352 3/20 0.46
JMJD6 Q6NYC1 1/20 0.46
GSK3B P49841 1/20 0.46
PIK3C3 Q8NEB9 1/20 0.45
HSD17B10 Q99714 1/20 0.44
RAB9A P51151 3/20 0.43
NPC1 O15118 2/20 0.43
HSP90AA1 P07900 1/20 0.43
HTT P42858 1/20 0.42
HPGD P15428 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19616912 0.83 KDM4E (0.50) KDM4EKDM6BKDM5CKDM4CKDM2A
SCHEMBL19615772 0.83 KDM4E (0.50) KDM4EKDM6BKDM5CKDM4CKDM2A
SCHEMBL70350 0.82 KDM4E (0.62) KDM4EKDM6BKDM5CKDM4CKDM2A
SCHEMBL30065796 0.82 KDM4E (0.62) KDM4EKDM6BKDM5CKDM4CKDM2A
SCHEMBL19631900 0.81 KDM4A (0.65) KDM4EKDM6BKDM5CKDM4CKDM2A
SCHEMBL30753282 0.80 RAB9A (0.49) KDM4EALDH1A1GSK3BPIK3C3HSD17B10
SCHEMBL4938486 0.79 SMYD3 (0.57) KDM4EKDM6BKDM5CKDM4CKDM2A
SCHEMBL30378954 0.79 KDM4E (0.58) KDM4EKDM6BKDM5CKDM4CKDM2A
SCHEMBL30779113 0.79 KDM4E (0.68) KDM4EKDM6BKDM5CKDM4CKDM2A
SCHEMBL475565 0.79 KDM4E (0.68) KDM4EKDM6BKDM5CKDM4CKDM2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017198785-A1 OXIME DERIVATIVES USEFUL AS INHIBITORS OF HISTONE DEMETHYLASE KDM4C IEO - ISTITUTO EUROPEO DI ONCOLOGIA S.R.L. (IT) 2017-11-23 WO disclosed